Fundraising Fox

Orca Bio

California, US · Founded 2015 · Delaware corporation · 6 known investors

orcabio.com

Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.

BiotechDigital HealthHealthtechMedical Devicesin /orcabio@orcabio

Founders & leadership

JJeroen
JeroenCo-founder and President
ID
Ivan DimovExecutive Officer, Director
NF
Nathaniel FernhoffExecutive Officer, Director
AK

Investors · 6

Competitors · 6

by search overlap

Companies competing with Orca Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$192MraisedJul 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex KolicichDirector
  • Ivan DimovExecutive Officer, Director
  • Jonathan MacQuittyDirector
  • Nathaniel FernhoffExecutive Officer, Director
Offering amount
$192M
Amount sold
$192M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news